Original ArticleIndian Journal of Pharmaceutical Education and ResearchVol. 59 | Issue 3s | 2025 | pp. s1066–s1073Open access
Effect of Wedelia chinensis Leaf Extracts against Ethylene Glycol Induced Urolithiasis in Rats
- 1*,
- 2
- 1 Department of Pharmacognosy, D.S.T.S. Mandal’s College of Pharmacy, Solapur, Maharashtra, INDIA.
- 2 Department of Pharmaceutical Quality Assurance, D.S.T.S. Mandal’s College of Pharmacy, Solapur, Maharashtra, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: Sunil Sidramayya Mathapati
Department of Pharmacognosy, D.S.T.S. Mandal’s College of Pharmacy, Solapur, Maharashtra, INDIA.
Email: sunilmathapaticops@gmail.com
Copyright: © 2025 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2025
- Received:
- Jan 27, 2025
- Accepted:
- Jun 9, 2025
- DOI:
- 10.5530/ijper.20256632
How to cite
Mathapati, S. S., & Kalshetti, M. (2025). Effect of Wedelia chinensis Leaf Extracts against Ethylene Glycol Induced Urolithiasis in Rats. Indian Journal of Pharmaceutical Education and Research, 59(3s), s1066–s1073. https://doi.org/10.5530/ijper.20256632
Abstract
Background
Finding a hyperoxaluria treatment that especially targets lowering oxalate excretion is essential due to the drawbacks of present urolithiasis treatments. It's interesting to note that Wedelia chinensis (Family: Asteraceae) leaves are used traditionally by several Indian tribes for treating renal disease.
Objectives
The current study aimed to assess the effectiveness of W. chinensis leaf extracts as therapeutic agents in rats with experimentally induced calcium oxalate urolithiasis.
Materials and Methods
Rats were given 0.75% ethylene glycol orally to induce calcium oxalate lithiasis for fourteen days in succession. W. chinensis leaf extracts, 400 mg/kg body weight in aqueous and ethanolic forms, were administered in the same way for a further 14 days in succession. The standard antiurolithiatic medicine used was cystone, administered at a dose of 750 mg/kg body weight. The study focused on the measurement of serum biochemical indicators and the excretion of salt components in the urine and renal deposits of the elements which were shown to be challenging.
Results
Ethylene glycol administered orally caused hyperoxaluria and increased calcium and phosphate renal excretion. Nevertheless, W. chinensis leaf extracts significantly reduced the elevated oxalate levels in the urine, indicating an inhibitory action on internal oxalate synthesis. The renal accumulation of components that cause stone formation in rats with calculogenic conditions decreased considerably after the administration of curative treatments with aqueous and ethanolic extracts.
Discussion and Conclusion
In accordance with the results, W. chinensis leaves possess lithontriptic action that justifies more research towards a possible treatment for urolithiasis. Further study is required to isolate and clarify the active phytoconstituents found in leaves responsible for their antiurolithiatic effects.
Keywords
Subject
Article metadata
| Title | Effect of Wedelia chinensis Leaf Extracts against Ethylene Glycol Induced Urolithiasis in Rats |
|---|---|
| Authors | Sunil Sidramayya Mathapati; Mallinath Kalshetti |
| Affiliations | Department of Pharmacognosy, D.S.T.S. Mandal’s College of Pharmacy, Solapur, Maharashtra, INDIA.; Department of Pharmaceutical Quality Assurance, D.S.T.S. Mandal’s College of Pharmacy, Solapur, Maharashtra, INDIA. |
| Corresponding author | sunilmathapaticops@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 59, Issue 3s (2025) |
Also in this issue
- Mesoporous Silica Nanoparticles: A Promising Portal for Diagnosis and Treatment for Chronic Diseasespp. s776–s787
- Nanostructured Lipid Carrier to Improve Oral Bioavailabilitypp. s788–s801
- A Review on Preparation Methods of Drug Loading Solid Lipid Nanoparticles with the Application in various Cancer Treatmentpp. s802–s813
- A Comprehensive Review on Management of Insulin Resistance Disorder by Innovative Technologies and Advancement of Precision Medicinal Therapiespp. s814–s824
- Formulation and Evaluation of Orally Disintegrating Tablet Containing Aripiprazole in the Context of Quality by Design Approachpp. s825–s836